Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625963 · ClinicalTrials.gov registry record
The Study Of CT Scans and Echo Parameters in Patients With PAH
A clinical trial of Pulmonary Hypertension, sponsored by Northwell Health.
- Completed
- Registry status
- 71
- Enrollment target
- 1
- Study location
NCT00625963 is a study of Pulmonary Hypertension that has completed, run by Northwell Health. The registered enrollment target is 71 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00625963, a study of Pulmonary Hypertension, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patterns of the PAH disease processes.
Conditions Studied
Study Locations (1)
New York
- North Shore-Long Island Jewish Health System - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00625963
The ClinicalTrials.gov registry entry for NCT00625963 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (88% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT00625963 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00625963 about?
NCT00625963 is a clinical study titled "The Study Of CT Scans and Echo Parameters in Patients With PAH". Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patte...
What is the current status of trial NCT00625963?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2007-04. Estimated completion is 2011-07.
What conditions does trial NCT00625963 study?
This clinical trial studies the following conditions: Pulmonary Hypertension.
Who is sponsoring clinical trial NCT00625963?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00625963 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.